Ars TechnicaFDA Reverses Huntington’s Gene Therapy Rejection After Leadership ShiftA groundbreaking one-time gene therapy for Huntington’s disease inches closer to approval after regulators reversed a controversial FDA rejection tied to Trump-era officials.Jun 17, 2026